Osteoporosis in long term care. Part 2 of 2: treatment strategies.
Gloth
F Michael
FM
Johns Hopkins University School of Medicine, USA.
D000058:Accidental Falls / Q000517:prevention & control; D000368:Aged; D002116:Calcitonin / Q000627:therapeutic use; D004164:Diphosphonates / Q000627:therapeutic use; D015914:Estrogen Replacement Therapy; D005851:Geriatric Nursing / Q000379:methods; D006801:Humans; D008134:Long-Term Care / Q000379:methods*; D009735:Nursing Homes; D010024:Osteoporosis / Q000150:complications / Q000628:therapy*; D018579:Patient Selection; D018570:Risk Assessment; D012307:Risk Factors; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D019379:Teriparatide / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D004164:Diphosphonates; D020845:Selective Estrogen Receptor Modulators; D019379:Teriparatide; D002116:Calcitonin